When cleared, Fujirebio’s FDA-designated breakthrough device is expected to be among the first commercially available in vitro diagnostics for patients being evaluated for Alzheimer’s disease in the US
The Isohelix GeneFiX™ saliva RNA collection device facilitates simplified, reliable COVID-19 testing at Precision Genetics’ laboratory under the US FDA EUA